Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TScan Therapeutics, Inc. - Common Stock (NQ:TCRX)

0.2772 +0.0018 (+0.65%)
Delayed Quote Updated: 11:30 AM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TScan Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Unusual volume stocks in Tuesday's session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
Here are the top movers in Wednesday's session. ↗
Via Chartmill
Which stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Breaking Down TScan Therapeutics: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 5 Takes On TScan Therapeutics ↗
 
Via Benzinga
News headline image
Which stocks are moving on Monday? ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews ↗
 
Via Benzinga
News headline image
Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 7 Takes On TScan Therapeutics ↗
 
Via Benzinga
News headline image
Gapping stocks in Monday's session ↗
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
News headline image
Discover the top movers in Monday's pre-market session. ↗
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Key Takeaways From TScan Therapeutics Analyst Ratings ↗
 
Via Benzinga
News headline image
Unveiling 4 Analyst Insights On TScan Therapeutics ↗
 
Via Benzinga
News headline image
TScan Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Recap: TScan Therapeutics Q3 Earnings ↗
 
Via Benzinga
News headline image
Which stocks are moving on Wednesday? ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
What Analysts Are Saying About TScan Therapeutics Stock ↗
 
Via Benzinga
News headline image
Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is TScan Therapeutics Stock Gaining Today? ↗
TScan Therapeutics' stock rises after announcing a $30 million financing deal with Lynx1, extending its cash runway into 2027. 
Via Benzinga
News headline image
TCRX Stock Earnings: TScan Therapeutics Meets EPS, Misses Revenue for Q2 2024 ↗
TCRX stock results show that TScan Therapeutics met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
TCRX Stock Earnings: TScan Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗
TCRX stock results show that TScan Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With ↗
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator. 
Via InvestorPlace
News headline image
TCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023 ↗
TCRX stock results show that TScan Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.